Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation × fluzoparib × 1 year × Clear all

Sponsor

Conditions

Sarcoma 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Sarcoma, Ewing 1 SCLC, Extensive Stage 1 Fludzoparib" and Anti-angiogenic 1 Breast Neoplasms 1 Advanced Solid Tumors 1 Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡